Britt I. Drögemöller

CancerCare Manitoba — Canada

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

29h-index2.4kcitations111works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(19), Genomics and Rare Diseases(18), Genetic Associations and Epidemiology(17), Metabolism and Genetic Disorders(9), Genetics and Neurodevelopmental Disorders(9)

Publications110 total

Distinct cochlear cell types associated with genetic susceptibility to sensory and metabolic hearing loss in older adults from the CLSA
2026Open Access
Short tandem repeats significantly contribute to the genetic architecture of metabolic and sensory age-related hearing loss phenotypes
2026Open Access
Navigating the Genetic Risk of Chemotherapy‐Induced Hearing Loss in the Stria Vascularis
Clinical Pharmacology & Therapeutics·2025Open Access
Uncovering the genetic relationship between dementia and age‐related hearing loss
Alzheimer s & Dementia·2025Open Access
Unbiased human genomic characterization of polyglutamine disorder genes to guide biological understanding and therapeutic strategies
Human Genetics and Genomics Advances·2025Open Access
Large-scale audiometric phenotyping identifies distinct genes and pathways involved in hearing loss subtypes
Communications Biology·2025· 3 citedOpen Access
<i>SCN3A</i> -related neurodevelopmental disorder: Clinical case reports and biophysical characterization
Channels·2025Open Access
Genetic Variations in Bitter Taste Receptors and COVID-19 in the Canadian Longitudinal Study on Aging
Biomedicines·2025· 1 citedOpen Access
Human germline biallelic loss-of-function <i>OSMR</i> variants cause severe allergic disease
2025Open Access
ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma
The Journal of Experimental Medicine·2025· 2 cited
Unbiased human genomic characterization of polyglutamine disorder genes to guide biological understanding and therapeutic strategies
2025Open Access
Large-scale audiometric phenotyping identifies distinct genes and pathways involved in hearing loss subtypes
2025Open Access
Bitter taste genetics and oral health in Canadian Longitudinal Study on Aging
2024· 1 citedOpen Access
Leveraging large-scale datasets and single cell omics data to develop a polygenic score for cisplatin-induced ototoxicity
Human Genomics·2024· 3 citedOpen Access
A multi-centre, tolerability study of a cannabidiol-enriched Cannabis Herbal Extract for chronic headaches in adolescents: The CAN-CHA protocol
PLoS ONE·2024· 1 citedOpen Access
Risk and Resilience Variants in the Retinoic Acid Metabolic and Developmental Pathways Associated with Risk of FASD Outcomes
Biomolecules·2024· 1 citedOpen Access
212 Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV–Associated Hodgkin Lymphoma
Clinical Immunology·2024· 1 cited
CIAO1 and MMS19 deficiency: A lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disorders
Genetics in Medicine·2024· 10 citedOpen Access
Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV–Associated Hodgkin Lymphoma
2023Open Access
Current Perspectives on Data Sharing and Open Science in Pharmacogenomics
Clinical Pharmacology & Therapeutics·2023· 1 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Galen E.B. Wright(29), Colin J.D. Ross(28), Wyeth W. Wasserman(16), Maja Tarailo‐Graovac(15), Louise Warnich(14), Bruce Carleton(10), Dana Niehaus(8), Clara van Karnebeek(7), Amit P. Bhavsar(6), Clara D.M. van Karnebeek(6), Casper Shyr(5), Ron A. Wevers(5), Robin Emsley(5), Lize van der Merwe(5), Michael R. Hayden(4), David Twesigomwe(4), Scott Hazelhurst(4), Liezl Koen(4), Jose Gerard Monzon(4), Beth Brooks(4)